ESC Professional Premium Access

Determinants of survival and morbidity in patients with congenital heart disease

Event: ESC Congress 2022
Topic: Congenital Heart Disease and Paediatric Cardiology
Session type: Abstract Sessions
Date: 28 August 2022
Time: 14:00 - 15:00

Congress Session

6 presentations in this session

Long-term survival in adults with congenital heart disease: a nationwide, register-based cohort study

Speaker: Associate Professor Z. Mandalenakis (Goteborg, SE)
Thumbnail

Patients with congenital heart disease over the age of 60: experiences of a single tertiary centre

Speaker: Miss D. Kecskemeti (Budapest, HU)
Thumbnail

Mortality in patients with Ebstein anomaly: a two-country, population-based cohort study including 530 patients

Speaker: Mr F. Eckerstrom (Copenhagen, DK)
Thumbnail

The patient with Down syndrome and pulmonary arterial hypertension associated with congenital heart disease: from childhood to adulthood

Speaker: Doctor R. Luna (Madrid, ES)
Thumbnail

Risk predictors and outcomes of infective endocarditis among adult patients with congenital heart disease

Speaker: Doctor M. Fedchenko (Gothenburg, SE)
Thumbnail

The risk spectrum of infective endocarditis among patients with congenital heart diseases

Speaker: Doctor E. Havers-Borgersen (Copenhagen, DK)
Thumbnail

6 speakers from this session

Associate Professor Zacharias Mandalenakis

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)
0 follower

Miss Dorottya Kecskemeti

Semmelweis University, Budapest (Hungary)
0 follower

Mr Filip Eckerstrom

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Raquel Luna

University Hospital 12 de Octubre, Madrid (Spain)
0 follower

Doctor Maria Fedchenko

Institute of Medicine, Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)
0 follower

Doctor Eva Havers-Borgersen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

This platform is supported by

logo Novo Nordisk